TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ELI LILLY & CO Stock

Certificat

DE000SU99249

Real-time Boerse Frankfurt Warrants 11:44:02 2024-05-30 EDT
53.51 EUR -0.98% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ELI LILLY & CO
Current month-6.21%
1 month-12.11%
Date Price Change
24-05-30 53.51 -0.98%
24-05-29 54.08 -0.61%
24-05-28 54.41 +1.55%
24-05-27 53.58 -0.89%
24-05-24 54.06 -0.61%

Real-time Boerse Frankfurt Warrants

Last update May 30, 2024 at 11:44 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Société Générale Société Générale
WKN SU9924
ISINDE000SU99249
Date issued 2024-03-05
Strike 1,393 $
Maturity Unlimited
Parity 10 : 1
Emission price 55.3
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 62.94
Lowest since issue 53.41
Spread 0.08
Spread %0.15%

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
811.5 USD
Average target price
850.8 USD
Spread / Average Target
+4.84%
Consensus